Tandem Diabetes COO David Berger to step down Dec 31, 2023

TANDEM DIABETES CARE INC

David B. Berger, EVP and COO, will leave his role effective December 31, 2023.
Berger oversaw clinical, quality, regulatory, legal, customer support, and operations.
He will provide transition advisory services to the company through 2024.
No successor named; terms of advisory agreement to be disclosed in a later filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David B. Berger

Executive Vice President and Chief Operating Officer

TNDM · TANDEM DIABETES CARE INC

Effective: 2023-12-31
Filed: November 13, 2023, 6:59 PM ET

On November 7, 2023, Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) and David B. Berger, the Company’s Executive Vice President and Chief Operating Officer, determined that he will be stepping down from his current position effective December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David B. Berger departed as Executive Vice President and Chief Operating Officer at TANDEM DIABETES CARE INC.

Action: stepping down
Role: Executive Vice President and Chief Operating Officer

Exact text from the filing

On November 7, 2023, Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) and David B. Berger, the Company’s Executive Vice President and Chief Operating Officer, determined that he will be stepping down from his current position effective December 31, 2023.

View on SEC.gov

TANDEM DIABETES CARE INC filing history →

Source: SEC EDGAR

accession 0001438133-23-000210

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.